Option Care Health

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Option Care Health surpasses Q4 expectations, eyes growth opportunities

Option Care Health's Q4 performance reflects growth and resilience amidst inflation challenges. The company's financial strength, focus on efficiency, and strategic initiatives position it well for future expansion and value creation.

Option Care Health reports robust Q2 earnings amidst strategic growth focus

Option Care Health's Q2 2023 earnings call highlighted strong financial performance, with revenue growth and adjusted EBITDA exceeding expectations. The company's strategic initiatives focus on innovation, operational efficiency, and patient care excellence.
While facing challenges like reimbursement issues and cost pressures, Option Care Health remains optimistic about sustainable growth and shareholder value. Investments in capabilities and network expansion position the company for future opportunities.
Analysts' inquiries into revenue growth composition, cost challenges, and future outlooks were addressed with a focus on operational excellence and sustainable growth. Option Care Health's performance reflects a balance of financial strength and strategic vision.

Option Care Health excels in Q3 performance and eyes M&A for growth

Option Care Health's Q3 earnings call highlighted strong financial performance, successful collaboration, and strategic focus on M&A for shareholder value. Challenges include revenue pressure in Q4 and sustainability of procurement benefits for 2024 projections.

Option Care Health exceeds revenue expectations, eyes strategic growth

Option Care Health's strong financial performance in 2023 positions the company for continued growth.
Strategic initiatives, operational efficiencies, and engagement with payers highlight the company's resilience.
Navigating market dynamics, optimizing procurement benefits, and strategic growth remain key focus areas for 2024.

Option Care Health reports resilient Q1 performance and growth opportunities

Option Care Health's Q1 2024 performance showcased revenue growth, strong patient satisfaction, and resilience in maintaining financial strength.
Despite challenges from the cybersecurity incident and supply chain disruptions, the company remains focused on growth and operational improvements.
Opportunities lie in expanding services, portfolio diversification, and adapting to evolving patient needs for continued success in 2024.
With disciplined SG&A management and a commitment to patient care, Option Care Health is poised for growth and service expansion.

Option Care Health excels in Q2, boosts revenue outlook

Option Care Health's Q2 performance reflects resilience and strategic focus, driving revenue growth and operational efficiency.
Despite challenges, the company's strengths in financial management and capital deployment position it well for future opportunities.
With increased revenue expectations and a strong cash flow rebound, Option Care Health is poised for sustained growth and value creation.

Option Care Health reports resilient Q3 performance amid operational challenges

Option Care Health's Q3 2024 performance showcased growth and financial resilience amidst operational challenges.
The company's strategic focus on managing costs and pursuing growth initiatives positions it well to address upcoming gross margin pressures.
Despite facing headwinds, Option Care Health remains optimistic about its revenue outlook for the full year 2024 and beyond.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Infusion therapy services provider Option Care Health (NASDAQ: OPCH) stock has been relatively strong during the market turmoil as it continues to trade near its 52-week highs.

Option Care Health Stock is Making a Healthy Pullback

Option Care Health is expanding its position in chronic illness infusion therapy, increasing its physician networks, and strengthening relationships with insurance companies. The total addressable market for infusion therapy is approximately $100 billion, with approximately 14% currently addressed.

Option Care Health: Top Infusion Therapy Player With Promising Growth Prospects

Option Care Health, Inc. (NASDAQ:OPCH ) Q1 2022 Earnings Conference Call April 28, 2022 8:30 AM ET Company Participants Mike Shapiro - Chief Financial Officer and Senior Vice President John Rademacher - Chief Executive Officer Conference Call Participants Matt Larew - William Blair Lisa Gill - J.P. Morgan David Macdonald - Truist Brooks O'Neil - Lake Street Capital Kieran Ryan - Deutsche Bank Joanna Gajuk - Bank of America Jamie Perse - Goldman Sachs Operator Thank you for standing by, and welcome to the Option Care Health First Quarter 2022 Earnings Conference Call.

Option Care Health's (OPCH) CEO John Rademacher on Q1 2022 Results - Earnings Call Transcript

Option Care (OPCH) delivered earnings and revenue surprises of 30.77% and 9.14%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Surpasses Q1 Earnings and Revenue Estimates

BANNOCKBURN, Ill., April 28, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced financial results for the first quarter ended March 31, 2022.

Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2022

BANNOCKBURN, Ill., April 12, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the largest independent provider of home and alternate site infusion services in the United States, announced today that it has completed the acquisition of Specialty Pharmacy Nursing Network Inc. (“SPNN”). SPNN is a national leader in providing highly skilled specialty nursing resources across a broad portfolio of healthcare providers with over 400 nurses across the country.

Option Care Health Completes Acquisition of Specialty Pharmacy Nursing Network Inc.

BANNOCKBURN, Ill., April 07, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2022 on Thursday, April 28, 2022 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce First Quarter 2022 Financial Results and Host Conference Call

Option Care Health's (OPCH) CEO John Rademacher on Q4 2021 Results - Earnings Call Transcript

Option Care (OPCH) delivered earnings and revenue surprises of 0% and 0.80%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Option Care (OPCH) Q4 Earnings Meet Estimates

BANNOCKBURN, Ill., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2021.

Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2021 and Announces Two Additional Acquisitions

Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Option Care (OPCH) is Poised to Beat Earnings Estimates Again

BANNOCKBURN, Ill., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent national provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2021 on Wednesday, February 23, 2022 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.

Option Care Health to Announce Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call

Globus Medical

Omnicell

Here we discuss three major subsectors of MedTech and three constituent stocks, OPCH, GMED and OMCL for which the change in the scenario has opened up enormous growth prospects.

Omicron Hits Elective MedTechs, 3 Subsectors Likely to Thrive

OVERLAND PARK, Kan.--(BUSINESS WIRE)--WellSky and Option Care Health Inc. today announced they will launch CommonWell Health Alliance services in Quarter 2 of 2022 in all 50 states.

WellSky® and Option Care Health to Launch CommonWell Services in All 50 States to Facilitate Health Information Exchange

Option Care Health, Inc. (OPCH) CEO John Rademacher on Q3 2021 Results - Earnings Call Transcript

BANNOCKBURN, Ill., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2021.

Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2021

Option Care (OPCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Option Care (OPCH) Earnings Expected to Grow: Should You Buy?

BANNOCKBURN, Ill., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH) (“Option Care Health” or the “Company”) announced today that it priced its offering of $500 million in aggregate principal amount of 4.375% senior notes due 2029 (the “Notes”) at an issue price of 100.000% (the “Offering”). Concurrently with the Offering, the Company priced its $600 million aggregate principal amount of amended and restated term loan B facility (the “New First Lien Term Loan Facility”).

Option Care Health Announces Pricing of Offering of $500 Million 4.375% Senior Notes and Amendment and Extension of First Lien Term Loan

BANNOCKBURN, Ill., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH) (“Option Care Health” or the “Company”) announced today that it intends to offer $500 million in aggregate principal amount of senior notes due 2029 (the “Notes”), subject to market and other conditions (the “Offering”). Concurrently with the Offering, the Company intends to amend or amend and restate its existing first lien term loan B facility (the “Existing First Lien Term Loan Facility”) to provide for $600.0 million of refinancing borrowings, to extend its maturity to 2028 and to make certain other changes (the “New First Lien Term Loan Facility”).

Option Care Health Announces Offering of $500 Million of Senior Notes and Amendment and Extension of First Lien Term Loan

BANNOCKBURN, Ill., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: OPCH) (“Option Care Health” or the “Company”), the nation's largest independent provider of home and alternate site infusion services, announced today its preliminary financial results for the third quarter ended September 30, 2021.

Option Care Health Announces Preliminary Financial Results for the Third Quarter Ended September 30, 2021 and Schedules Third Quarter Earnings Call

BANNOCKBURN, Ill., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the largest independent provider of home and alternate site infusion services in the United States, announced today that it has acquired Infinity Infusion Nursing, LLC (“Infinity”). Infinity is a leader in home infusion services that provide therapy management for patients with acute, chronic and rare disorders through a national network of highly-skilled, specialty nurses.

Option Care Health Acquires Infinity Infusion Nursing, LLC

Quest Diagnostics

Maravai LifeSciences Holdings

Walgreens

West Pharmaceutical Services

Stocks like West Pharmaceuticals Services (WST), Maravai LifeSciences (MRVI) and Option Care Health (OPCH) have gained stupendously year to date.

3 High-Potential MedTech Stocks With More Than 50% Growth YTD

Option Care (OPCH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Option Care (OPCH) Upgraded to Strong Buy: What Does It Mean for the Stock?

Ares Management

Canadian Natural Resources

Range Resources

RRC, OPCH, CNQ, and ARES made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 14, 2021.

Top Ranked Momentum Stocks to Buy for September 14th

If you are looking for stocks that are well positioned to maintain their recent uptrend, Option Care (OPCH) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

News for Option Care Health Stock (OPCH)